title: Malignant pleural mesothelioma: overview of the North American and European experience.
abstract: MPM is an uncommon disease with limited treatment options. Early diagnosis, a standardized staging system, early referral to centers experienced in MPM, and efforts to develop collaborative multicenter trials are essential to improving treatment for patients with MPM. Efforts to manage this malignancy, which is projected to peak in the twenty-first century, constitute an important international health concern, particularly because the use of asbestos, despite successful regulatory efforts in many parts of the world, continues unabated in others.
authors.affiliation: Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
authors.forename: Jasleen
authors.initials: J
authors.lastname: Kukreja
authors.forename: Michael T
authors.initials: MT
authors.lastname: Jaklitsch
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Wiener
authors.forename: David J
authors.initials: DJ
authors.lastname: Sugarbaker
authors.forename: Sjaak
authors.initials: S
authors.lastname: Burgers
authors.forename: Paul
authors.initials: P
authors.lastname: Baas
mesh_terms: D003131:Combined Modality Therapy; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008654:Mesothelioma / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D009367:Neoplasm Staging; D009656:North America / Q000453:epidemiology; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate